세계의 소아 완화 치료 의약품 시장 : 약제 클래스별, 투여 경로별, 유통 채널별, 지역별 - 규모, 점유율, 전망, 기회 분석(2023-2030년)
Pediatric Palliative Care Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023-2030
상품코드
:
1350265
리서치사
:
Coherent Market Insights
발행일
:
2023년 08월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 소아 완화 치료 의약품(Pediatric Palliative Care Drugs) 시장은 2023년에 831억 달러로 추정되며 예측 기간(2023-2030년)의 CAGR은 5.1%로 예측됩니다.
| 보고 대상 범위 |
보고서 세부정보 |
| 기준년도 |
2022년 |
2023년 시장 규모 |
미국 : 831억 달러 |
| 과거 데이터 |
2018-2021년 |
예측 기간 |
2023-2030년 |
| 예측 기간(2023-2030년)의 CAGR : |
5.10% |
2030년 가치 예측 |
미국 1,178억 달러 |
소아 완화 치료는 심각한 질병을 앓고 있는 어린이를 위한 전문 의료 서비스입니다. 완화 치료는 질병의 증상과 스트레스를 완화하는 데 중점을 둡니다. 목표는 어린이와 가족 모두의 삶의 질을 개선하는 것입니다. 소아 완화 치료는 모든 연령과 질병의 모든 단계에 적합합니다. 신생아, 주산기, 영아, 어린이, 청소년, 청년에게 적합하며 치료와 함께 제공될 수 있습니다. 소아 완화 치료는 유전 질환, 암, 미숙아, 신경 장애, 심장 및 폐 질환 등을 포함한 심각한 의학적 상태를 다룹니다. 통증, 숨가쁨, 피로, 변비, 메스꺼움, 식욕 부진, 수면 장애, 불안 및 우울증과 같은 이러한 질병의 증상을 완화합니다. 요컨대, 아이와 가족의 삶의 질을 개선하는 데 도움이 됩니다. 소아 완화 치료는 생명을 위협하는 질환을 앓고 있는 어린이와 그 가족의 삶의 질을 개선하기 위한 학제 간 협력입니다. 세계보건기구(WHO)는 소아 완화의료를 어린이의 몸과 마음, 정신에 대한 적극적인 총체적 치료로 정의하며, 여기에는 가족에 대한 지원도 포함됩니다. 완화 치료에 가장 일반적으로 사용되는 약물은 파라세타몰, 이부프로펜, 모르핀, 비사코딜, 메트로니다졸, 돔페리돈, 덱사메타손, 디아제팜 등 다양합니다. 또한 신부전, 근위축성 측삭 경화증(ALS), 암, 파킨슨병, 만성 폐쇄성 폐질환(COPD), 울혈성 심부전(CHF)과 같은 만성 질환과 같은 심각한 장애를 치료하는 데에도 사용됩니다.
시장 역학
신제품 출시 증가와 주요 시장 플레이어의 인수 합병이 글로벌 소아 완화 치료 약물 시장 성장을 주도 할 것으로 예상됩니다. 예를 들어, 2022년 4월 1일 일본에 본사를 둔 제약회사 Eisai Co., Ltd.는 디지털 솔루션 사업 기반을 강화하고 빠르게 확장하기 위해 일본에 본사를 둔 헬스케어 블록체인 스타트업인 Arteryex Inc.를 인수한다고 발표했습니다. 두 회사는 환자, 의료 전문가 및 사회 전반을 위한 개인 건강 기록(PHR) 관련 서비스를 개발하고 제공하기 위해 협력할 예정입니다.
주요 특징
- 세계의 소아 완화 치료 의약품 시장을 상세하게 분석하여 2022년을 기준년도로 한 예측 기간(2023-2030년) 시장 규모 및 연간 평균 성장률(CAGR)을 제공합니다.
- 다양한 부문에 걸친 잠재적인 매출 성장 기회를 밝히고, 이 시장에 대한 매력적인 투자 제안의 행렬에 대해 설명합니다.
- 또한 시장 성장 촉진 요인, 억제 요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 세계의 소아 완화 치료 의약품 시장의 주요 기업을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등 매개변수를 기반으로 프로파일링하고 있습니다.
- 대상이 되는 주요 기업으로는 Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co.,Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc. Inc.를 포함합니다.
- 통찰을 통해 마케팅 담당자와 기업 경영진은 향후 제품 상시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 투자자, 공급업체, 제품 제조업체, 판매자, 신규 참여자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 소아 완화 치료 의약품 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정이 용이해집니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 범위
- 보고서 개요
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 최근 제품 상시
- 역학
- 합병, 인수, 제휴
- 규제 시나리오
- 주요 발전
- PEST 분석
제4장 소아 완화 치료 의약품 시장 : COVID-19 영향 분석
- 경제적 영향
- COVID-19 역학
- 수요 및 공급에 미치는 영향
제5장 소아 완화 치료 의약품 시장 : 약제 클래스별(2018-2030년)
- 진통제
- 구토 방지제
- 완하제
- 보조약물
- 스테로이드
- 진정제
- 신경 차단제
- 기타
제6장 소아 완화 치료 의약품 시장 : 투여 경로별(2018-2030년)
제7장 소아 완화 치료 의약품 시장 : 유통 채널별(2018-2030년)
제8장 소아 완화 치료 의약품 시장 : 지역별(2018-2030년)
- 북미
- 미국
- 캐나다
- 남미
- 브라질
- 멕시코
- 아르헨티나
- 기타 남미
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아 태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아 태평양
- 중동
- GCC
- 이스라엘
- 기타 중동
- 아프리카
- 북아프리카
- 중앙 아프리카
- 남아프리카
제9장 경쟁 구도
- Novartis International AG
- Mylan NV
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Anqiu Lu'an Pharmaceutical Co., Ltd.
- Granules India Limited
- Zhejiang Kangle Pharmaceutical Co., Ltd.
- Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Atabay Pharmaceutical Factory
- Anhui Fubore Pharmaceutical & Chemical Co., Ltd.
- Huzhou Konch Pharmaceutical Co., Ltd.
- Alnylam Pharmaceuticals Inc.
- Eton Pharmaceuticals, Inc.
- Eisai Inc.
제10장 섹션
LYJ
영문 목차
Global pediatric palliative care drugs market is estimated to be valued at US$ 83.1 billion in 2023 and is expected to exhibit a CAGR of 5.1% during the forecast period (2023-2030).
| Report Coverage |
Report Details |
| Base Year: |
2022 |
Market Size in 2023: |
US$ 83.1 Bn |
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: |
5.10% |
2030 Value Projection: |
US$ 117.8 Bn |
Pediatric palliative care is specialized medical care for children living with a serious illness. Palliative care focuses on providing relief from the symptoms and stress of the illness. The goal is to improve quality of life for both the child and the family. Pediatric palliative care is appropriate at any age and any stage of illness. It is appropriate for neonates, perinates, infants, children, adolescents, and young adults, and it can be provided along with treatment. Pediatric palliative care addresses serious medical conditions including genetic disorders, cancer, prematurity, neurologic disorders, heart and lung conditions, and others. It relieves the symptoms of these diseases such as pain, shortness of breath, fatigue, constipation, nausea, loss of appetite and difficulty sleeping, anxiety and depression. In short, it helps the child and the family improve their quality of life. Pediatric palliative care is an interdisciplinary collaboration that seeks to improve the quality of life for children with life-threatening conditions, as well as their families. The World Health Organization (WHO) defines pediatric palliative care as the active total care of the child's body, mind and spirit, which also involves giving support to the family. Different drugs most commonly used in palliative care are paracetamol, ibuprofen, morphine, bisacodyl, metronidazole, domperidone, dexamethasone, and diazepam. It is also used to treat serious disorders like chronic diseases such as kidney failure, Amyotrophic Lateral Sclerosis (ALS), cancer, Parkinson's disease, Chronic Obstructive Pulmonary Disease (COPD), and Congestive Heart Failure (CHF).
Market Dynamics
Increasing new product launches, and mergers and acquisitions by key market players are expected to drive the global pediatric palliative care drugs market growth. For instance, on April 1, 2022, Eisai Co., Ltd., a Japan-based pharmaceutical company announced the acquisition of Arteryex Inc., a Japan-based healthcare blockchain startup, to strengthen and rapidly expand the foundation of its digital solution business. The two companies will work together to develop and provide Personal Health Record (PHR)-related services for patients, healthcare professionals, and society at large.
Key features of the study:
- This report provides an in-depth analysis of the global pediatric palliative care drugs market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pediatric palliative care drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co.,Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pediatric palliative care drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric palliative care drugs market
Detailed Segmentation:
- Global Pediatric Palliative Care Drugs Market, By Drug Class:
- Analgesics
- Anti-emetics
- Laxatives
- Adjuvant Medications
- Steroids
- Sedatives
- Neuroleptic Medications
- Others
- Global Pediatric Palliative Care Drugs Market, By Route of Administration:
- Global Pediatric Palliative Care Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Pediatric Palliative Care Drugs Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Novartis International AG
- Mylan NV
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Anqiu Lu'an Pharmaceutical Co., Ltd.
- Granules India Limited
- Zhejiang Kangle Pharmaceutical Co., Ltd.
- Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Atabay Pharmaceutical Factory
- Anhui Fubore Pharmaceutical & Chemical Co., Ltd
- Huzhou Konch Pharmaceutical Co., Ltd.
- Alnylam Pharmaceuticals Inc.
- Eton Pharmaceuticals, Inc
- Eisai Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Pediatric Palliative Care Drugs Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Pediatric Palliative Care Drugs Market, By Drug Class, 2018-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Anti-emetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Adjuvant Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Steroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Sedatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Neuroleptic Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
6. Global Pediatric Palliative Care Drugs Market, By Route of Administration, 2018-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
7. Global Pediatric Palliative Care Drugs Market, By Distribution Channel, 2018-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
8. Global Pediatric Palliative Care Drugs Market , By Region, 2018-2030, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Billion)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amneal Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Anqiu Lu'an Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Granules India Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zhejiang Kangle Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Atabay Pharmaceutical Factory
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Anhui Fubore Pharmaceutical & Chemical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Huzhou Konch Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alnylam Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eton Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eisai Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
관련자료
